Table 1.
Baseline characteristics of patients who underwent endoscopic reintervention following EUS-guided hepaticogastrostomy
| Patient characteristics | n=33, n (%) |
|---|---|
| Median age, years (IQR) | 72 (67–76) |
| Sex (male/female) | 22 (66.7)/11 (33.3) |
| ECOG performance status (0/1/2) | 15 (45.5)/15 (45.5)/3 (9.1) |
| Underlying malignancy | |
| Gastric cancer | 9 (27.3) |
| Bile duct cancer | 9 (27.3) |
| Pancreatic cancer | 8 (24.2) |
| Hepatocellular carcinoma | 3 (9.1) |
| Others | 4 (12.1) |
| Location of MBO | |
| Distal MBO/proximal MBO | 18 (54.5)/15 (45.5) |
| Duodenal stent placement | 6 (18.2) |
| Indication for EUS-HGS | |
| Failure of duodenal scope insertion | 11 (33.3) |
| Surgically altered gastrointestinal anatomy | 10 (30.3) |
| Failure of biliary cannulation | 12 (36.4) |
| Procedural details of EUS-HGS | |
| Procedure time (min), median (IQR) | 27 (20–40) |
| Type of L-PCMS | |
| Stent diameter (8 mm/10 mm) | 26 (78.8)/7 (21.2) |
| Stent length (10 cm/12 cm) | 26 (78.8)/7 (21.2) |
| Intragastric stent length, median (IQR) | 5 (5.2–5.8) |
| Time to RBO after EUS-HGS (days), median (IQR) | 104 (56–263) |
ECOG: Eastern Cooperative Oncology Group; EUS-HGS: EUS-guided hepaticogastrostomy; IQR: Interquartile range; L-PCMS: Long partially covered metal stent; MBO: Malignant biliary obstruction; RBO: Recurrent biliary obstruction